A Study to Evaluate the Safety and Efficacy of Nivolumab With Ipilimumab in Participants With Untreated Advanced Kidney Cancer Conducted in India
Clinical trial NCT04513522 · COMPLETED
Trial details
- NCT number
- NCT04513522
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-17
- Primary completion
- 2024-01-04
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.